Zolmitriptan dosage forms and strengths

Zolmitriptan

ZOLMITRIPTAN® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Zolmitriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Dosage Forms and Strengths

[edit | edit source]

2.5 mg Orally Disintegrating Tablets: White to off white, round tablets debossed ‘F7’ on one side and plain on the other side.

5 mg Orally Disintegrating Tablets: White to off-white, round tablets debossed ‘F11’on one side and plain on the other side.[1]

## References

[edit | edit source]

1. ↑ "ZOLMIPTRIPTAN (ZOLMITRIPTAN) TABLET, ORALLY DISINTEGRATING [GLENMARK GENERICS INC.,USA]".

Adapted from the FDA Package Insert.